Sequana Medical NV (EBR:SEQUA)

Belgium · Delayed Price · Currency is EUR

0.6110

0.00 (0.00%)

Apr 28, 2026, 5:35 PM CET

Sequana Medical NV Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	0	0.11	0.71	0.92	0.37	0.96
Revenue Growth	-	-85.19%	-22.81%	149.04%	-61.54%	-0.76%
Gross Profit	-0	0.08	0.55	0.72	0.29	0.76
Operating Income	-17.21	-18.22	-28.86	-28.09	-22.61	-17.77
Net Income	-51.85	-44.65	-32.56	-30.76	-23.62	-19.11
Earnings Per Share	-1.23	-1.22	-1.22	-1.35	-1.30	-1.25
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Germany	0.09	0.55	0.69	0.32	0.69
France	0.02	0.1	0.11	0.04	0.17
Switzerland	-	0.04	0.09	0.02	0.06
Rest of The World	-	0.02	0.03	-	0.04
Total	0.11	0.71	0.92	0.37	0.96

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	7.31	3.81	2.58	18.87	9.6	11.02
Total Debt	47.99	47.5	20.29	19.16	8.09	7.86
Net Cash (Debt)	-40.67	-43.69	-17.7	-0.29	1.52	3.16
Net Cash Growth	-	-	-	-	-52.00%	33.66%
Net Cash Per Share	-0.87	-1.19	-0.66	-0.01	0.08	0.21

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	-17.63	-20.26	-29.06	-27.48	-23.62	-17.01
Capital Expenditures	-0.07	-0.1	-0.71	-0.68	-0.33	-0.14
Free Cash Flow	-17.69	-20.35	-29.77	-28.16	-23.94	-17.14
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Gross Margin	-	74.94%	76.95%	77.83%	79.31%	78.99%
Operating Margin	-	-17273.00%	-4052.70%	-3044.86%	-6103.55%	-1844.85%
Pretax Margin	-	-42059.94%	-4507.05%	-3292.17%	-6267.69%	-1967.15%
Profit Margin	-	-42325.70%	-4572.42%	-3334.08%	-6373.84%	-1983.45%
FCF Margin	-	-19292.20%	-4180.74%	-3051.80%	-6462.39%	-1779.67%

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Forward PE	-	2.14	2.14	2.14	-	-
PS Ratio	-	1288.86	158.63	154.42	379.06	193.28